According to information provided by Bloomberg Ratings, the twelve investment firms actively tracking the stock of PerkinElmer, INC (NYSE: PKI) have collectively assigned a rating of “Hold” to the company.
There are a total of ten investment analysts who have the opinion that shareholders should increase their holdings in the company; however, only five of them believe that shareholders should buy more shares of the company.
Brokers who increased their stock coverage during the previous year have, on average, set a price target of $166.30 per share for the stock for the next 12 months.
This price target will take into account future dividends.
PerkinElmer (NYSE: PKI) disclosed the outcomes of its most recent quarterly earnings report on Tuesday, February 14.
In the medical research company’s quarterly report, the earnings per share came in at $1.70, $0.04 higher than the average expectation of $1.66.
Even though market watchers had forecast that the company would bring in $1.07 billion in sales for the quarter, the actual revenue that the company brought in was only $741.20 million.
According to the numbers provided, PerkinElmer had a return on equity of 13.94% and a net margin of 14.69%. Compared to the same quarter’s results in the previous year, PerkinElmer reported a revenue decrease of 27.9%.
The earnings per share for the current year come in at $2.56, which is lower than the results for the same quarter of the previous year, which were $3.14.
The analysts who conduct equity research anticipate that PerkinElmer will generate earnings of $5.06 per share in this fiscal year.
When Thursday’s trading began, PKI’s price was $122.54 per share.
During the previous year, the price of a PerkinElmer stock share dropped to a low of $113.46 while reaching an all-time high of $184.75.
It has a price-to-earnings ratio of 26.76, a PEG ratio of 0.51, and a beta value of 1.10; these three metrics, in addition to its overall market value of $15.49 billion, all contribute to its value.
The moving average of the company’s stock price over the previous 200 days is $133.40, and the moving average over the previous 50 days is $132.88.
The current, quick, and debt-to-equity ratios are all at 2.13, whereas the debt-to-equity ratio stands at 0.53.
Recent times have seen the company receive feedback from various equity research analysts who have been following the company’s progress. Cowen raised their rating on PerkinElmer from “market perform” to “outperform” in a research report published on Tuesday, December 6, and they set a target price of $164.00 for the shares.
In a research report released on Monday, December 12, Citigroup raised their price target for PerkinElmer from $135.00 to $170.00 and changed their rating for the company from “neutral” to “buy.” Both of these changes were made to the company’s stock. Robert W.
Baird decreased their price objective on PerkinElmer from $185.00 to $182.00 in a research note published on Wednesday, February 15.
In addition to that, they gave the business an “outperform” rating.
Barclays decreased their target price on PerkinElmer from $145.00 to $140.00 and gave the company an “equal weight” rating in a research note published on Tuesday, January 24. Cowen downgraded PerkinElmer from an “outperform” rating to a “market perform” rating in a research report published on Tuesday, December 6.
This was the very last and most significant change to the rating.
In addition, they lowered the price target they had set for the stock, which had previously been set at $192.00.
The new price target is now $164.00.
In addition, the company has declared a quarterly dividend, which will be paid out on May 12. On April 21, stockholders of record will be eligible to receive a dividend payment of $0.07 per share.
This payment will be made available to them. Shareholders with accounts in good standing as of April 20 will be eligible to receive this dividend.
This translates to an annual dividend payment of $0.28 and a dividend yield of 0.23%. When we look at it on an annualized basis.
The current dividend payout ratio (DPR) for PerkinElmer is 6.11%.
This number may change in the future.
On December 20, 2018, company insider Tajinder S. Vohra sold 1,663 shares of the company’s stock.
This information was divulged in a different report of recent events. For $138.85 per share, a total of $230,907.55’s worth of the stock was traded, accumulating cash.
The average price paid per share was $138.85.
The company insider owns 17,205 shares, and the total value of those shares is $2,388,914.25.
If you follow this link, you will be taken to the filing submitted to the Securities and Exchange Commission, where the transaction was discussed, and it will take you there immediately.
The management of the company and the employees collectively own 0.52% of the total shares in the company.